{
  "abstract": "We read with great interest the randomised controlled trial by Singh et al regarding the efficacy of adjunctive dexamethasone in children with severe community-acquired pneumonia (CAP).1 We commend the authors for their innovative and significant contributions to the field, demonstrating a significant reduction in treatment failure at 72 hours, an outcome that may have substantial implications for paediatric clinical practice in resource-limited settings. However, we wish to offer a few points that may further enrich this discussion.",
  "authors": [
    {
      "affiliations": [
        "Universidade Positivo Curso de Medicina, Curitiba, Parana, Brazil"
      ],
      "name": "Leticia Sayuri Kinoshita Assahide"
    },
    {
      "affiliations": [
        "Positivo University, Curitiba, Brazil"
      ],
      "name": "Gustavo Pichel Kakuda"
    }
  ],
  "title": "Outcome of early short course corticosteroid therapy in severe community-acquired pneumonia",
  "uid": "6f6fdadf-f836-5430-b932-1acae5d9540b"
}